Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | Novoeight® (Antihemophilic Factor [Recombinant]) | Novoeight® for |
Description | Is it time to reconsider your treatment for hemophilia Prescribing Information Important Safety Information For Health Care Professionals About Novo Nordisk en Español Novoeight® Patient Home Why Novoeight ® P |
Keywords | N/A |
WebSite | novoeight.com |
Host IP | 72.3.137.119 |
Location | United States |
Site | Rank |
US$4,766,614
Last updated: 2023-05-14 09:00:51
novoeight.com has Semrush global rank of 2,220,508. novoeight.com has an estimated worth of US$ 4,766,614, based on its estimated Ads revenue. novoeight.com receives approximately 549,994 unique visitors each day. Its web server is located in United States, with IP address 72.3.137.119. According to SiteAdvisor, novoeight.com is safe to visit. |
Purchase/Sale Value | US$4,766,614 |
Daily Ads Revenue | US$4,400 |
Monthly Ads Revenue | US$131,999 |
Yearly Ads Revenue | US$1,583,983 |
Daily Unique Visitors | 36,667 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
novoeight.com. | A | 300 | IP: 72.3.137.119 |
novoeight.com. | NS | 86400 | NS Record: ns.rackspace.com. |
novoeight.com. | NS | 86400 | NS Record: ns2.rackspace.com. |
novoeight.com. | TXT | 86400 | TXT Record: sf91cn3hrjsb75s4kqw4p54h1t0p8gmh |
novoeight.com. | TXT | 86400 | TXT Record: google-site-verification=6BaNYdd86SfVd7OlwvS5MD8YRAjzbF17FeskRncAy0k |
Prescribing Information Important Safety Information For Health Care Professionals About Novo Nordisk en Español Novoeight® Patient Home Why Novoeight ® Portability Effectiveness Safety Profile Patient Stories Choosing a Treatment Know Your Options Costs for You Starting Treatment Welcome Getting Your Factor Preparing for an Infusion Performing an Infusion Getting Support How We Can Help At a Glance Product Support Hemophilia Education Contact Us Is it time to reconsider your treatment for hemophilia A? If you are looking for a FVIII product that’s ready to go, controls bleeds, and has an established safety profile, Novoeight ® offers all 3. Meet Novoeight ® Is it time to reconsider your treatment for hemophilia A? If you are looking for a FVIII product that’s ready to go, controls bleeds, and has an established safety profile, Novoeight ® offers all 3. Meet Novoeight ® Malcolm lives with hemophilia A. Need a treatment that’s designed to go with you? Novoeight ® is the only standard |
HTTP/1.1 301 Moved Permanently Date: Thu, 23 Dec 2021 04:14:10 GMT Server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 Location: https://www.novoeight.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Thu, 23 Dec 2021 04:14:10 GMT server: Apache/2.4.43 (IUS) OpenSSL/1.0.2k-fips Communique/4.3.2 last-modified: Wed, 22 Dec 2021 17:27:55 GMT etag: "1a88e-5d3bf713b0685" accept-ranges: bytes content-length: 108686 vary: Accept-Encoding content-disposition: inline content-type: text/html; charset=UTF-8 |
Domain Name: NOVOEIGHT.COM Registry Domain ID: 1471108933_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.dynadot.com Registrar URL: http://www.dynadot.com Updated Date: 2021-05-13T04:28:56Z Creation Date: 2008-05-13T09:13:50Z Registry Expiry Date: 2022-05-13T09:13:50Z Registrar: DYNADOT, LLC Registrar IANA ID: 472 Registrar Abuse Contact Email: abuse@dynadot.com Registrar Abuse Contact Phone: +16502620100 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS.RACKSPACE.COM Name Server: NS2.RACKSPACE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:25:12Z <<< |